🧠AI Analysis
Findings from the ZEUS Trial Question the Role of IL-6 Inhibition in Cardiovascular Disease
Recent findings from the ZEUS clinical trial indicate that neutralizing interleukin-6 with ziltivekimab did not reduce cardiovascular events in patients suffering from at…